LYRA | Lyra Therapeutics, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.1745 - 0.1850
52 Week Range	0.1630 - 6.79
Beta	-0.67
Implied Volatility	430.94%
IV Rank	88.73%
Day's Volume	1,416,292
Average Volume	1,414,795
Shares Outstanding	65,457,700
Market Cap	11,815,115
Sector	Healthcare
Industry	Biotechnology
IPO Date	2020-05-01

Valuation
Profitability
Growth
Health
P/E Ratio	-0.12
Forward P/E Ratio	N/A
EPS	-1.49
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	88
Country	USA
Website	LYRA

Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase II clinical trial; and LYR-220 for CRS patients with and without nasal polyps. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.

LYRA's peers: ALDX, APLT, AUTL, CDMO, CGEM, CGTX, CLSD, CRDF, CRMD, DBVT, DMAC, EQ, ETON, FDMT, CMPX, GOSS, HRMY, HUMA, IMCR, IMRX, IOBT, JSPR, KALV, KNSA, KPTI, KRON, LCTX, LQDA, LTRN, CTMX, ASMB, ACHL, NLTX, TIL, NXTC, SPRO, NUVB, BOLT, DAWN, MIRM, NVCT, PHAT, RANI, REPL, ROIV, SCPH, SLNO, SRZN, TARA, THTX, TRVI, VINC, VIRX, VOR, VYNE, MAIA, ELVN

*Chart delayed

Analyzing fundamentals for LYRA we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see LYRA Fundamentals page.

Watching at LYRA technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on LYRA Technicals page.